SEA Constituency concluded a productive engagement at the Global Fund’s 54th Board Meeting in Geneva, Switzerland from 11-13 February 2026 at the Global Health Campus.

SEA Constituency delivered nine formal interventions and held seven bilateral meetings with the Implementer Group Leadership, Canada/Switzerland/Australia, the UK, Western Pacific, Roll Back Malaria, the Chair of the Board Leadership Nominations Committee, and WHO. Two key decisions were adopted: approval of US$260 million for GC8 Catalytic Investments (supplemented by private sector contributions) and confirmation of US$10.78 billion for GC8 country allocations, 6.6% lower than GC7, with further differentiation based on economic capacity and disease burden.

SEA consistently conveyed the importance of ensuring that allocation reductions do not undermine the significant gains achieved in SEA, particularly in TB control and malaria elimination, and the Secretariat will finalize and communicate country allocations in the coming months.